The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunoglobulins-Global Market Insights and Sales Trends 2024
Synopsis
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
The global Immunoglobulins market size is expected to reach US$ 13870 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulins in various end use industries. The expanding demands from the Hospital and Research, are propelling Immunoglobulins market. IgG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgA segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunoglobulins market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunoglobulins market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulins covered in this report include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc.
The global Immunoglobulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Global Immunoglobulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulins market, Segment by Type:
IgG
IgA
IgM
IgE
IgD
Global Immunoglobulins market, by Application
Hospital
Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
The global Immunoglobulins market size is expected to reach US$ 13870 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulins in various end use industries. The expanding demands from the Hospital and Research, are propelling Immunoglobulins market. IgG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgA segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunoglobulins market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunoglobulins market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulins covered in this report include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc.
The global Immunoglobulins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Global Immunoglobulins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulins market, Segment by Type:
IgG
IgA
IgM
IgE
IgD
Global Immunoglobulins market, by Application
Hospital
Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immunoglobulins Market Overview
1.1 Immunoglobulins Product Overview
1.2 Immunoglobulins Market Segment by Type
1.2.1 IgG
1.2.2 IgA
1.2.3 IgM
1.2.4 IgE
1.2.5 IgD
1.3 Global Immunoglobulins Market Size by Type
1.3.1 Global Immunoglobulins Market Size Overview by Type (2018-2029)
1.3.2 Global Immunoglobulins Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immunoglobulins Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunoglobulins Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immunoglobulins Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immunoglobulins Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immunoglobulins Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immunoglobulins Sales Breakdown by Type (2018-2023)
2 Global Immunoglobulins Market Competition by Company
2.1 Global Top Players by Immunoglobulins Sales (2018-2023)
2.2 Global Top Players by Immunoglobulins Revenue (2018-2023)
2.3 Global Top Players by Immunoglobulins Price (2018-2023)
2.4 Global Top Manufacturers Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunoglobulins Market Competitive Situation and Trends
2.5.1 Immunoglobulins Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunoglobulins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulins as of 2022)
2.7 Date of Key Manufacturers Enter into Immunoglobulins Market
2.8 Key Manufacturers Immunoglobulins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immunoglobulins Status and Outlook by Region
3.1 Global Immunoglobulins Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immunoglobulins Historic Market Size by Region
3.2.1 Global Immunoglobulins Sales in Volume by Region (2018-2023)
3.2.2 Global Immunoglobulins Sales in Value by Region (2018-2023)
3.2.3 Global Immunoglobulins Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immunoglobulins Forecasted Market Size by Region
3.3.1 Global Immunoglobulins Sales in Volume by Region (2024-2029)
3.3.2 Global Immunoglobulins Sales in Value by Region (2024-2029)
3.3.3 Global Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immunoglobulins by Application
4.1 Immunoglobulins Market Segment by Application
4.1.1 Hospital
4.1.2 Research
4.2 Global Immunoglobulins Market Size by Application
4.2.1 Global Immunoglobulins Market Size Overview by Application (2018-2029)
4.2.2 Global Immunoglobulins Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immunoglobulins Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immunoglobulins Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immunoglobulins Sales Breakdown by Application (2018-2023)
5 North America Immunoglobulins by Country
5.1 North America Immunoglobulins Historic Market Size by Country
5.1.1 North America Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immunoglobulins Sales in Volume by Country (2018-2023)
5.1.3 North America Immunoglobulins Sales in Value by Country (2018-2023)
5.2 North America Immunoglobulins Forecasted Market Size by Country
5.2.1 North America Immunoglobulins Sales in Volume by Country (2024-2029)
5.2.2 North America Immunoglobulins Sales in Value by Country (2024-2029)
6 Europe Immunoglobulins by Country
6.1 Europe Immunoglobulins Historic Market Size by Country
6.1.1 Europe Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immunoglobulins Sales in Volume by Country (2018-2023)
6.1.3 Europe Immunoglobulins Sales in Value by Country (2018-2023)
6.2 Europe Immunoglobulins Forecasted Market Size by Country
6.2.1 Europe Immunoglobulins Sales in Volume by Country (2024-2029)
6.2.2 Europe Immunoglobulins Sales in Value by Country (2024-2029)
7 Asia-Pacific Immunoglobulins by Region
7.1 Asia-Pacific Immunoglobulins Historic Market Size by Region
7.1.1 Asia-Pacific Immunoglobulins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immunoglobulins Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immunoglobulins Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immunoglobulins Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunoglobulins Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immunoglobulins Sales in Value by Region (2024-2029)
8 Latin America Immunoglobulins by Country
8.1 Latin America Immunoglobulins Historic Market Size by Country
8.1.1 Latin America Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immunoglobulins Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immunoglobulins Sales in Value by Country (2018-2023)
8.2 Latin America Immunoglobulins Forecasted Market Size by Country
8.2.1 Latin America Immunoglobulins Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immunoglobulins Sales in Value by Country (2024-2029)
9 Middle East and Africa Immunoglobulins by Country
9.1 Middle East and Africa Immunoglobulins Historic Market Size by Country
9.1.1 Middle East and Africa Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immunoglobulins Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immunoglobulins Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immunoglobulins Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunoglobulins Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immunoglobulins Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hualan Biological Engineering Inc.
10.1.1 Hualan Biological Engineering Inc. Company Information
10.1.2 Hualan Biological Engineering Inc. Introduction and Business Overview
10.1.3 Hualan Biological Engineering Inc. Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Hualan Biological Engineering Inc. Immunoglobulins Products Offered
10.1.5 Hualan Biological Engineering Inc. Recent Development
10.2 Omrix Biopharmaceuticals Ltd.
10.2.1 Omrix Biopharmaceuticals Ltd. Company Information
10.2.2 Omrix Biopharmaceuticals Ltd. Introduction and Business Overview
10.2.3 Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Omrix Biopharmaceuticals Ltd. Immunoglobulins Products Offered
10.2.5 Omrix Biopharmaceuticals Ltd. Recent Development
10.3 Behring GmbH
10.3.1 Behring GmbH Company Information
10.3.2 Behring GmbH Introduction and Business Overview
10.3.3 Behring GmbH Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Behring GmbH Immunoglobulins Products Offered
10.3.5 Behring GmbH Recent Development
10.4 Shanghai RAAS Blood Products
10.4.1 Shanghai RAAS Blood Products Company Information
10.4.2 Shanghai RAAS Blood Products Introduction and Business Overview
10.4.3 Shanghai RAAS Blood Products Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shanghai RAAS Blood Products Immunoglobulins Products Offered
10.4.5 Shanghai RAAS Blood Products Recent Development
10.5 Option Care Enterprises
10.5.1 Option Care Enterprises Company Information
10.5.2 Option Care Enterprises Introduction and Business Overview
10.5.3 Option Care Enterprises Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Option Care Enterprises Immunoglobulins Products Offered
10.5.5 Option Care Enterprises Recent Development
10.6 ADMA Biologics,
10.6.1 ADMA Biologics, Company Information
10.6.2 ADMA Biologics, Introduction and Business Overview
10.6.3 ADMA Biologics, Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ADMA Biologics, Immunoglobulins Products Offered
10.6.5 ADMA Biologics, Recent Development
10.7 BioScrip
10.7.1 BioScrip Company Information
10.7.2 BioScrip Introduction and Business Overview
10.7.3 BioScrip Immunoglobulins Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BioScrip Immunoglobulins Products Offered
10.7.5 BioScrip Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunoglobulins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunoglobulins Industrial Chain Analysis
11.4 Immunoglobulins Market Dynamics
11.4.1 Immunoglobulins Industry Trends
11.4.2 Immunoglobulins Market Drivers
11.4.3 Immunoglobulins Market Challenges
11.4.4 Immunoglobulins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunoglobulins Distributors
12.3 Immunoglobulins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
